HIV Co-Receptor CCR5: Structure and Interactions with Inhibitors

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Relationship Between the Chemokine Receptor CCR5 and Microglia in Neurological Disorders: Consequences of Targeting CCR5 on Neuroinflammation, Neuronal Death and Regeneration in a Model of Epilepsy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-09 ,pp. : 815-829

Bentham Science Publishers

Access to resources Recommend Favorite

CCR5 antagonists for the treatment of HIV

By Schmitz Jens  

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 277-282

Govi-Verlag

Access to resources Recommend Favorite

The CCR5 receptor antagonist maraviroc reduces viral load in patients with HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite